Evidence map›Paper›PMID 26114118›Full record

ArticleBioMed research international2015

miR-1322 Binding Sites in Paralogous and Orthologous Genes.

Raigul Niyazova, Olga Berillo, Shara Atambayeva, Anna Pyrkova, Aigul Alybayeva, Anatoly Ivashchenko

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in genetics · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Raigul NiyazovaNational Nanotechnology Laboratory, Al-Farabi Kazakh National University, 71 Al-Farabi, Almaty 050038, Kazakhstan.
Olga BerilloNational Nanotechnology Laboratory, Al-Farabi Kazakh National University, 71 Al-Farabi, Almaty 050038, Kazakhstan.
Shara AtambayevaNational Nanotechnology Laboratory, Al-Farabi Kazakh National University, 71 Al-Farabi, Almaty 050038, Kazakhstan.
Anna PyrkovaNational Nanotechnology Laboratory, Al-Farabi Kazakh National University, 71 Al-Farabi, Almaty 050038, Kazakhstan.
Aigul AlybayevaNational Nanotechnology Laboratory, Al-Farabi Kazakh National University, 71 Al-Farabi, Almaty 050038, Kazakhstan.
Anatoly IvashchenkoNational Nanotechnology Laboratory, Al-Farabi Kazakh National University, 71 Al-Farabi, Almaty 050038, Kazakhstan.
Al-Farabi Kazakh National University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We searched for 2,563 microRNA (miRNA) binding sites in 17,494 mRNA sequences of human genes. miR-1322 has more than 2,000 binding sites in 1,058 genes with ΔG/ΔG m ratio of 85% and more. miR-1322 has 1,889 binding sites in CDSs, 215 binding sites in 5' UTRs, and 160 binding sites in 3' UTRs. From two to 28 binding sites have arranged localization with the start position through three nucleotides of each following binding site. The nucleotide sequences of these sites in CDSs encode oligopeptides with the same and/or different amino acid sequences. We found that 33% of the target genes encoded transcription factors. miR-1322 has arranged binding sites in the CDSs of orthologous MAMLD1, MAML2, and MAML3 genes. These sites encode a polyglutamine oligopeptide ranging from six to 47 amino acids in length. The properties of miR-1322 binding sites in orthologous and paralogous target genes are discussed.

Indexed as

Genome, Human3' Untranslated RegionsBase SequenceBinding SitesComputational BiologyConserved SequenceHumansMicroRNAsRNA, Messenger3' Untranslated RegionsMicroRNAsMIRN1322 microRNA, humanRNA, Messenger

Identifiers

PMID26114118
PMCPMC4465656
OpenAlexW1495652769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.